These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

381 related articles for article (PubMed ID: 21651460)

  • 1. The dynamics of urinary N-acetyl-β-D-glucosaminidase (NAG), a marker of renal tubular dysfunction, in patients with lupus nephritis undergoing oral prednisone therapy.
    Gluhovschi C; Velciov S; Kaycsa A; Gluhovschi G; Petrica L; Marian R; Bozdog G; Gadalean F; Bob F; Cioca D; Vernic C
    Immunopharmacol Immunotoxicol; 2012 Feb; 34(1):163-9. PubMed ID: 21651460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum cystatin C level for better assessment of glomerular filtration rate in cystic fibrosis patients treated by amikacin.
    Halacova M; Kotaska K; Kukacka J; Vavrova V; Kuzelova M; Ticha J; Prusa R
    J Clin Pharm Ther; 2008 Aug; 33(4):409-17. PubMed ID: 18613859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary N-acetyl-beta-glucosaminidase excretion is a marker of tubular cell dysfunction and a predictor of outcome in primary glomerulonephritis.
    Bazzi C; Petrini C; Rizza V; Arrigo G; Napodano P; Paparella M; D'Amico G
    Nephrol Dial Transplant; 2002 Nov; 17(11):1890-6. PubMed ID: 12401843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subclinical tubular injury in HIV-infected individuals on antiretroviral therapy: a cross-sectional analysis.
    Hall AM; Edwards SG; Lapsley M; Connolly JO; Chetty K; O'Farrell S; Unwin RJ; Williams IG
    Am J Kidney Dis; 2009 Dec; 54(6):1034-42. PubMed ID: 19783343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measurement of urinary N-acetyl-b-D-glucosaminidase in adult patients with cystic fibrosis: before, during and after treatment with intravenous antibiotics.
    Etherington C; Bosomworth M; Clifton I; Peckham DG; Conway SP
    J Cyst Fibros; 2007 Jan; 6(1):67-73. PubMed ID: 16844430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The effect of blood pressure-reducing therapy with captopril on tubular marker excretion in type-1 diabetics with nephropathy].
    Ratzmann KP; Raskovic M; Schimke E
    Dtsch Med Wochenschr; 1994 Jun; 119(22):796-800. PubMed ID: 8205941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beta-2-microglobulin is superior to N-acetyl-beta-glucosaminidase in predicting prognosis in idiopathic membranous nephropathy.
    Hofstra JM; Deegens JK; Willems HL; Wetzels JF
    Nephrol Dial Transplant; 2008 Aug; 23(8):2546-51. PubMed ID: 18308774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Uric acid excretion and dopamine-induced glomerular filtration response in patients with IgA glomerulonephritis.
    Sulikowska B; Manitius J; Odrowaz-Sypniewska G; Łysiak-Szydłowska W; Rutkowski B
    Am J Nephrol; 2008; 28(3):391-6. PubMed ID: 18063857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urinary N-acetyl-beta-D-glucosaminidase (NAG) in lupus nephritis and rheumatoid arthritis.
    Erdener D; Aksu K; Biçer I; Doğanavşargil E; Kutay FZ
    J Clin Lab Anal; 2005; 19(4):172-6. PubMed ID: 16025478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect on proteinuria and urinary NAG of treatment with meloxicam in chronic glomerular disease patients--a preliminary study.
    Gluhovschi G; Velciov S; Kaycsa A; Trandafirescu V; Petrica L; Bozdog G; Gluhovschi C; Bob F; Vernic C
    Int J Clin Pharmacol Ther; 2009 Jul; 47(7):444-53. PubMed ID: 19640351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urinary N-acetyl-beta-D-glucosaminidase as a diagnostic marker of acute pyelonephritis in children.
    Mohkam M; Karimi A; Habibian S; Sharifian M
    Iran J Kidney Dis; 2008 Jan; 2(1):24-8. PubMed ID: 19367005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tubular functions in familial Mediterranean fever.
    Akkuş S; Calişkan S; Kasapçopur O
    Turk J Pediatr; 2002; 44(4):317-20. PubMed ID: 12458807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary biomarkers in assessing the nephrotoxic potential of gentamicin in solitary kidney patients after 7 days of therapy.
    Gluhovschi G; Gadalean F; Gluhovschi C; Velciov S; Petrica L; Bob F; Bozdog G; Kaycsa A
    Ren Fail; 2014 May; 36(4):534-40. PubMed ID: 24456153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A pilot study of low-dose fludarabine in membranous nephropathy refractory to therapy.
    Boumpas DT; Tassiulas IO; Fleisher TA; Vaughan E; Piscitelli S; Kim Y; Pucino F; Balow JE; Austin HA
    Clin Nephrol; 1999 Aug; 52(2):67-75. PubMed ID: 10480216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Captopril effect on prostaglandin E2, thromboxane B2 and proteinuria in lupus nephritis patients.
    Daza L; Kornhauser C; Zamora L; Flores J
    Prostaglandins Other Lipid Mediat; 2005 Dec; 78(1-4):194-201. PubMed ID: 16303616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized pilot trial comparing cyclosporine and azathioprine for maintenance therapy in diffuse lupus nephritis over four years.
    Moroni G; Doria A; Mosca M; Alberighi OD; Ferraccioli G; Todesco S; Manno C; Altieri P; Ferrara R; Greco S; Ponticelli C
    Clin J Am Soc Nephrol; 2006 Sep; 1(5):925-32. PubMed ID: 17699309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone mineral density and urinary N-acetyl-beta-D-glucosaminidase activity in paediatric patients with idiopathic hypercalciuria.
    Skalova S; Palicka V; Kutilek S
    Nephrology (Carlton); 2005 Apr; 10(2):99-102. PubMed ID: 15877664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tacrolimus versus cyclophosphamide as treatment for diffuse proliferative or membranous lupus nephritis: a non-randomized prospective cohort study.
    Wang S; Li X; Qu L; Wang R; Chen Y; Li Q; He X; Zhang X; Wang H; Wu J; Xu Y; Chen J
    Lupus; 2012 Aug; 21(9):1025-35. PubMed ID: 22570338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tubular damage in chronic systolic heart failure is associated with reduced survival independent of glomerular filtration rate.
    Damman K; Van Veldhuisen DJ; Navis G; Vaidya VS; Smilde TD; Westenbrink BD; Bonventre JV; Voors AA; Hillege HL
    Heart; 2010 Aug; 96(16):1297-302. PubMed ID: 20659949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Albuminuria, proteinuria, and novel urine biomarkers as predictors of long-term allograft outcomes in kidney transplant recipients.
    Nauta FL; Bakker SJ; van Oeveren W; Navis G; van der Heide JJ; van Goor H; de Jong PE; Gansevoort RT
    Am J Kidney Dis; 2011 May; 57(5):733-43. PubMed ID: 21458900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.